Moreover, the prognostic analysis of the TCGA CRC cohort revealed that CRC patients with higher ANGPTL2, COLEC11, and SPP1 tend to undergo worse overall survival (Figure 3C). This evidence concerns the gene ANGPTL2 and colorectal carcinoma.